What is the alternative imaging study for evaluating the adrenal glands when a patient cannot undergo contrast-enhanced MRI?

Alternative Imaging for Adrenal Glands When Contrast-Enhanced MRI is Contraindicated

If a patient cannot undergo contrast-enhanced MRI, the best alternative is non-contrast CT (NCCT) as the first-line test, followed by non-contrast MRI with chemical shift imaging (CSI) if additional characterization is needed. 1

Algorithmic Approach to Imaging Selection

First-Line: Non-Contrast CT (NCCT)

• NCCT is the key initial investigation for most adrenal lesions and serves as the primary alternative when contrast-enhanced MRI is unavailable 1
• Measures attenuation in Hounsfield Units (HU):
  • ≤10 HU: Diagnostic of benign adenoma (98% specificity, 71% sensitivity) 1
  • 11-20 HU: >90% of homogeneous lesions are benign 1
  • >30 HU: Indeterminate, requires further evaluation
• Also detects macroscopic fat (diagnostic of myelolipoma), calcification, and hemorrhage 1

Second-Line Options When NCCT is Indeterminate

Option 1: Non-Contrast MRI with Chemical Shift Imaging (CSI)

• Does not require contrast administration 1, 2
• Uses in-phase and opposed-phase T1-weighted sequences to detect intracellular lipid 1
• Signal loss on opposed-phase images indicates adenoma 1
• Most effective for lesions with NCCT attenuation 10-20 HU; less useful >30 HU 1
• Recent guidelines recommend MRI over contrast-enhanced CT when additional imaging is needed after NCCT 1
• Non-contrast MRI was shown to visualize the right adrenal vein in 84.8% of cases with 95.2% positive predictive value 3

Option 2: Adrenal Protocol CT (if contrast not contraindicated)

• Three-phase study: noncontrast, venous phase (60-70 seconds), delayed phase (15 minutes) 1
• Calculates contrast washout characteristics
• Important caveat: Up to 35% of pheochromocytomas and certain metastases (renal, hepatocellular) can mimic adenoma washout patterns 1
• Recent data shows washout CT is less accurate than previously reported 1, 2

Key Clinical Pitfalls to Avoid

1. Never biopsy before excluding pheochromocytoma - ensure functional testing is complete first 2

2. Lipid-rich adenomas on non-contrast imaging: If NCCT shows ≤10 HU in a homogeneous lesion ≥4 cm, repeat imaging at 6-12 months but no further functional testing needed if benign and non-functional 2

3. Myelolipomas: Macroscopic fat on NCCT or MRI is diagnostic; no further follow-up needed 2

4. Indeterminate lesions: If non-contrast studies remain indeterminate, shared decision-making between repeat imaging in 3-6 months versus surgical resection 2

Special Populations Where Non-Contrast MRI is Preferred

• Pediatric patients (avoid radiation) 1
• Pregnant patients 1
• Patients requiring serial screening (e.g., familial pheochromocytoma syndromes) 1
• Locally advanced tumors requiring soft tissue delineation 1

Summary of Imaging Hierarchy Without Contrast-Enhanced MRI

1. Start with NCCT - characterizes 71% of adenomas based on ≤10 HU threshold 1
2. If indeterminate (>10 HU): Proceed to non-contrast MRI with CSI 1, 2
3. If still indeterminate: Consider adrenal protocol CT with contrast (if not contraindicated) or FDG-PET in select cases with known extra-adrenal malignancy 1
4. All patients require functional testing regardless of imaging findings 2

The combination of NCCT followed by non-contrast MRI with CSI provides excellent diagnostic accuracy without requiring contrast administration, making this the optimal pathway when contrast-enhanced MRI cannot be performed.